Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Spinal Cord in Multiple Sclerosis: Magnetic Resonance Imaging Features and Differential Diagnosis.
Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases.
Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.
Similar Effects Seen for Fingolimod, Placebo in Primary Progressive Multiple Sclerosis
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Multiple sclerosis: Smoking in patients with multiple sclerosis-is it ever too late to quit?
The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Re: Prevalence of Sexual Dysfunctions among Women with Multiple Sclerosis.
CellCept Drug Details
Cavernous angioma: a clinical study of 35 cases with review of the literature.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.
MAG, myelin and overcoming growth inhibition in the CNS.
CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Gender, ethnicity, and physician-patient communication about depression and anxiety in primary care.
The effects of early maternal deprivation on auditory information processing in adult Wistar rats.
The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.
A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.
Pages
« first
‹ previous
…
723
724
725
726
727
728
729
730
731
…
next ›
last »